Article: The great need to overcome osimertinib resistance in advanced non-small cell lung cancer: from combination strategies to fourth-generation tyrosine kinase inhibitors.
2024 Volume 13, Page(s) 1308460
Language | English |
---|---|
Publishing date | 2024-01-09 |
Publishing country | Switzerland |
Document type | Journal Article |
ZDB-ID | 2649216-7 |
ISSN | 2234-943X |
ISSN | 2234-943X |
DOI | 10.3389/fonc.2023.1308460 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.